These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33109066)

  • 1. Evaluating the Risks of Systemic Maternal Ivermectin Exposure During Pregnancy in Human and Vertebrate Animals: A Scoping Review.
    Westlake CS; Aronoff DM
    Curr Drug Saf; 2021; 16(3):299-308. PubMed ID: 33109066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis.
    Gyapong JO; Chinbuah MA; Gyapong M
    Trop Med Int Health; 2003 Dec; 8(12):1093-101. PubMed ID: 14641844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
    Abegunde AT; Ahuja RM; Okafor NJ
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis.
    Brocklehurst P; French R
    Br J Obstet Gynaecol; 1998 Aug; 105(8):836-48. PubMed ID: 9746375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Pregnant Women with Ivermectin during Mass Drug Distribution: Time to Investigate Its Safety and Potential Benefits.
    Erber AC; Ariyo E; Olliaro P; Nicolas P; Chaccour C; Colebunders R
    Pathogens; 2021 Dec; 10(12):. PubMed ID: 34959543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin concentration in breastmilk of a woman with Strongyloides stercoralis and human T-lymphotropic virus-I co-infection.
    Rodari P; Buonfrate D; Pomari E; Lunardi G; Bon I; Bisoffi Z; Angheben A
    Acta Trop; 2020 Feb; 202():105249. PubMed ID: 31678122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
    Coppola D; Russo LJ; Kwarta RF; Varughese R; Schmider J
    Drug Saf; 2007; 30(3):247-64. PubMed ID: 17343431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin for onchocercal eye disease (river blindness).
    Ejere HO; Schwartz E; Wormald R; Evans JR
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002219. PubMed ID: 22895928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ivermectin].
    Boussinesq M
    Med Trop (Mars); 2005; 65(1):69-79. PubMed ID: 15903082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal dietary education and supplementation to increase energy and protein intake.
    Ota E; Hori H; Mori R; Tobe-Gai R; Farrar D
    Cochrane Database Syst Rev; 2015 Jun; (6):CD000032. PubMed ID: 26031211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of cetirizine in pregnancy.
    Golembesky A; Cooney M; Boev R; Schlit AF; Bentz JWG
    J Obstet Gynaecol; 2018 Oct; 38(7):940-945. PubMed ID: 29565188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of high-dose ivermectin: a systematic review and meta-analysis.
    Navarro M; Camprubí D; Requena-Méndez A; Buonfrate D; Giorli G; Kamgno J; Gardon J; Boussinesq M; Muñoz J; Krolewiecki A
    J Antimicrob Chemother; 2020 Apr; 75(4):827-834. PubMed ID: 31960060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sealing procedures for preterm prelabour rupture of membranes.
    Crowley AE; Grivell RM; Dodd JM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010218. PubMed ID: 27384151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution.
    Pacqué M; Muñoz B; Poetschke G; Foose J; Greene BM; Taylor HR
    Lancet; 1990 Dec; 336(8729):1486-9. PubMed ID: 1979100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WHO antenatal care randomised controlled trial: rationale and study design.
    Villar J; Bakketeig L; Donner A; al-Mazrou Y; Ba'aqeel H; Belizán JM; Carroli G; Farnot U; Lumbiganon P; Piaggio G; Berendes H
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():27-58. PubMed ID: 9805722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide.
    Gluck PA; Gluck JC
    Curr Med Res Opin; 2005 Jul; 21(7):1075-84. PubMed ID: 16004676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.